Valuation: RushNet, Inc.

Market Cap 12.26M 10.62M 10.01M 9.09M 17.05M 1.17B 17.19M 120M 46.06M 596M 46.06M 45.04M 1.89B P/E 2020
13.3x
P/E 2021 55x
Enterprise Value 18.19M 15.75M 14.85M 13.48M 25.29M 1.74B 25.5M 177M 68.33M 884M 68.33M 66.82M 2.81B EV / Sales 2020
2.75x
EV / Sales 2021 1.77x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week 0
Extreme 1.0E-6
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0.02
Manager TitleAgeSince
Chief Executive Officer - 03/03/2024
Chief Operating Officer 45 01/08/2021
Director TitleAgeSince
Chairman - 03/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 8.77K
+4.82%-1.70%-9.41%+52.90% 7.05B
+1.88%-0.55%-8.23%-16.31% 4B
+3.10%+8.88%+36.60% - 2.7B
+2.72%+0.33%-11.10%-29.82% 1.54B
+0.86%-14.55%+66.77%+1,780.00% 1.35B
+2.64%-2.35%-19.39%-16.48% 1.3B
-2.12%-6.74%+84.77% - 1.02B
-0.52%+0.68%-29.16%-19.76% 808M
+1.40%+12.41%+3.76%+10.51% 799M
Average +1.48%-2.22%+12.73%+251.58% 2.06B
Weighted average by Cap. +2.78%-3.27%+5.48%+156.15%

Financials

2020 2021
Net sales 4.39M 3.8M 3.58M 3.25M 6.1M 419M 6.15M 42.78M 16.48M 213M 16.48M 16.12M 677M 5.9M 5.11M 4.81M 4.37M 8.2M 563M 8.26M 57.49M 22.15M 287M 22.15M 21.66M 910M
Net income 991K 858K 809K 734K 1.38M 94.65M 1.39M 9.66M 3.72M 48.16M 3.72M 3.64M 153M 164K 142K 134K 121K 227K 15.63M 229K 1.59M 614K 7.95M 614K 601K 25.24M
Net Debt 5.87M 5.08M 4.79M 4.35M 8.16M 561M 8.23M 57.23M 22.05M 285M 22.05M 21.56M 906M 5.93M 5.13M 4.84M 4.39M 8.24M 566M 8.31M 57.8M 22.27M 288M 22.27M 21.78M 915M
Logo RushNet, Inc.
RushNet, Inc. provides management and insurance billing services to clinical laboratories and laboratory services. The Company’s subsidiaries include Chattahoochee Physicians Laboratory Services, LLC, doing business as HeliosDx, and Grandeza Healthcare Consultants, LLC (Grandeza). HeliosDx offers urine drug testing, allergy droplet cards, oral fluids, Polymerase Chain Reaction (PCR) for nails, wounds, respiratory pathogens, sexually transmitted infections, gastrointestinal issues, urinary tract infections, and pharmacogenomics testing through lab partners. Grandeza provides management and insurance billing services to clinical reference laboratories.
Employees
18
Date Price Change Volume
14/09/26 US$0.000001 0.00% 380,200
11/09/26 US$0.000001 0.00% 140,000
  1. Stock Market
  2. Stocks
  3. RSHN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!